| scholarly article | Q13442814 |
| P50 | author | Massimo Alfano | Q73268464 |
| P2093 | author name string | H Schmidtmayerova | |
| M Bukrinsky | |||
| T Pushkarsky | |||
| C A Amella | |||
| P2860 | cites work | HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 |
| Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 | ||
| A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors | Q28118386 | ||
| gp 120s derived from four syncytium-inducing HIV-1 strains induce different patterns of CD4 association with lymphocyte surface molecules | Q28246564 | ||
| Pertussis toxin and target eukaryotic cells: binding, entry, and activation | Q28269020 | ||
| The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates | Q28282895 | ||
| Pertussis toxin triggers rapid second messenger production in human T lymphocytes | Q70038268 | ||
| Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK | Q74106115 | ||
| Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120 | Q28287967 | ||
| CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 | Q28646859 | ||
| Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype | Q28646874 | ||
| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 | ||
| The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain | Q29618472 | ||
| Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein | Q30459108 | ||
| Evidence that lipopolysaccharide and pertussis toxin bind to different domains on the same p73 receptor on murine splenocytes | Q33619945 | ||
| Bacterial toxins affect early events of T lymphocyte activation | Q34564560 | ||
| G proteins | Q35557485 | ||
| Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes | Q35888738 | ||
| Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains | Q36186612 | ||
| CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction | Q36324324 | ||
| Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus | Q36352167 | ||
| Change in coreceptor use correlates with disease progression in HIV-1--infected individuals | Q36376800 | ||
| Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. | Q36380882 | ||
| Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. | Q36401415 | ||
| Pertussis toxin has eukaryotic-like carbohydrate recognition domains | Q36759213 | ||
| Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity | Q36765049 | ||
| The 70-kilodalton pertussis toxin-binding protein in Jurkat cells. | Q38307893 | ||
| Pharmacology of pertussis toxin B-oligomer | Q38358142 | ||
| The lymphocytosis-promoting agent pertussis toxin affects virus burden and lymphocyte distribution in the SIV-infected rhesus macaque | Q38501268 | ||
| HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. | Q38869431 | ||
| Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor | Q38878235 | ||
| The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection | Q38949380 | ||
| HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5. | Q39000361 | ||
| Human immunodeficiency virus-1 infection requires pertussis toxin sensitive G-protein-coupled signalling and mediates cAMP downregulation | Q39036696 | ||
| Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry | Q39464591 | ||
| Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level | Q39580343 | ||
| Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. | Q39581009 | ||
| Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor | Q39585768 | ||
| Lymphocyte receptors for pertussis toxin. | Q40429107 | ||
| Chemokine receptors and human immunodeficiency virus infection | Q41667150 | ||
| Identification of a 43-kilodalton human T lymphocyte membrane protein as a receptor for pertussis toxin. | Q41728052 | ||
| Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis | Q42951587 | ||
| Pertussis toxin activates protein kinase C and a tyrosine protein kinase in the human T cell line Jurkat | Q43525127 | ||
| Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection | Q45854138 | ||
| HIV-1 subtype and second-receptor use | Q59068400 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 597-605 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains | |
| P478 | volume | 190 |
| Q35155875 | AB toxins: a paradigm switch from deadly to desirable |
| Q21245460 | Asymmetric HIV-1 co-receptor use and replication in CD4(+) T lymphocytes |
| Q22251022 | Avoiding the void: cell-to-cell spread of human viruses |
| Q28140552 | Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk |
| Q56880736 | CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells |
| Q39605953 | CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells |
| Q39574200 | CXCR4 engagement is required for HIV-1–induced L-selectin shedding |
| Q36553987 | CXCR4-tropic, but not CCR5-tropic, human immunodeficiency virus infection is inhibited by the lipid raft-associated factors, acyclic retinoid analogs, and cholera toxin B subunit |
| Q34388037 | Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection |
| Q37730789 | Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa |
| Q33521304 | Chemokine coreceptor signaling in HIV-1 infection and pathogenesis |
| Q35050395 | Chemokine receptors: emerging opportunities for new anti-HIV therapies |
| Q42092694 | Differential contribution of chemotaxis and substrate restriction to segregation of immature and mature thymocytes |
| Q37849655 | Early events of HIV-1 infection: can signaling be the next therapeutic target? |
| Q39700255 | G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates |
| Q24676438 | HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation |
| Q28186856 | HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages |
| Q39119645 | HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis |
| Q37622627 | HIV-1 triggers WAVE2 phosphorylation in primary CD4 T cells and macrophages, mediating Arp2/3-dependent nuclear migration. |
| Q36324514 | Herpes simplex virus triggers activation of calcium-signaling pathways |
| Q37276208 | How to engage Cofilin |
| Q34234127 | Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors |
| Q33839349 | Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation |
| Q92538598 | Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections |
| Q35027627 | Interactions between opioid and chemokine receptors: heterologous desensitization |
| Q33728885 | Interference with the signaling capacity of CC chemokine receptor 5 can compromise its role as an HIV-1 entry coreceptor in primary T lymphocytes |
| Q38358628 | Investigating pertussis toxin and its impact on vaccination |
| Q38359214 | Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity |
| Q90729693 | Lipid Rafts and Pathogens: The Art of Deception and Exploitation |
| Q74121926 | Mechanisms of pertussis toxin-induced myelomonocytic cell adhesion: role of CD14 and urokinase receptor |
| Q47144668 | Novel Therapeutic Approach for Inhibition of HIV-1 Using Cell-Penetrating Peptide and Bacterial Toxins |
| Q24602050 | Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools |
| Q36396894 | Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection |
| Q37396782 | Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4. |
| Q24541375 | Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages |
| Q30478990 | Physiological levels of virion-associated human immunodeficiency virus type 1 envelope induce coreceptor-dependent calcium flux |
| Q24673772 | Pit2 assemblies at the cell surface are modulated by extracellular inorganic phosphate concentration |
| Q42824844 | Poxvirus infection rapidly activates tyrosine kinase signal transduction |
| Q40468585 | Role of HIV-2 envelope in Lv2-mediated restriction. |
| Q30865013 | Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells |
| Q24290736 | SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways |
| Q35022576 | Slit proteins, potential endogenous modulators of inflammation |
| Q24531215 | The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages |
| Q37899279 | The ins and outs of pertussis toxin |
| Q33810779 | The macrophage in HIV-1 infection: from activation to deactivation? |
| Q35748336 | The role of glycosphingolipids in HIV signaling, entry and pathogenesis |
| Q35741691 | The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages |
| Q38295129 | Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection |
| Q36911645 | Use of G-protein-coupled and -uncoupled CCR5 receptors by CCR5 inhibitor-resistant and -sensitive human immunodeficiency virus type 1 variants. |
| Q34055358 | Virus-induced Ca2+ influx extends survival of west nile virus-infected cells |
Search more.